Monday, 13 May 2024 12:27

Decision 848/2024

Clearance decision on the notified concentration, pursuant to articles 5-10 of Law 3959/2011, concerning the acquisition of joint control by the companies “STRIX ASSET MANAGEMENT LTD” and “FARALLON CAPITAL MANAGEMENT L.L.C.” over “EUROMEDICA HEALTHCARE SERVICES S.A.”, within the meaning of Article 5 of Law 3959/2011.

Decision 848/2024

File (PDF) Decision 848/2024
Date of Issuance of Decision May 13th,  2024
Issue Number of Government Gazette
Relevant Market

1. The private general hospital market
2. The private diagnostic center market

Subject of the Decision Clearance decision on the notified concentration, pursuant to articles 5-10 of Law 3959/2011, concerning the acquisition of joint control by the companies “STRIX ASSET MANAGEMENT LTD” and “FARALLON CAPITAL MANAGEMENT L.L.C.” over “EUROMEDICA HEALTHCARE SERVICES S.A.”, within the meaning of Article 5 of Law 3959/2011
Legal Framework

Article 6 of Law 3959/2011

Operative part of the Decision

The Hellenic Competition Commission (HCC), in Chamber, unanimously approved, pursuant to Art. 8(3) of Greek Law 3959/2011, the notified concentration (under ref. no 10180/29.12.2023) concerning the acquisition of joint control by the companies “STRIX ASSET MANAGEMENT LTD” and “FARALLON CAPITAL MANAGEMENT L.L.C.” over “EUROMEDICA HEALTHCARE SERVICES S.A.”, as this concentration, although falling within the scope of article 6(1) of the Greek Law 3959/2011, as in force, does not raise serious concerns regarding its compatibility with competition rules in the individual markets concerned.
Company(ies) concerned

1. “STRIX ASSET MANAGEMENT LTD”
2. “FARALLON CAPITAL MANAGEMENT L.L.C.”
3. “EUROMEDICA HEALTHCARE SERVICES S.A.”

The concentration consists in the acquisition by the company “STRIX ASSET MANAGEMENT LTD” of a 29.35% shareholding in the target company's “EUROMEDICA HEALTHCARE SERVICES S.A.” share capital, through “STRIX HOLDINGS ΙΙ L.P.”, a limited liability special purpose vehicle.

Summary of Decision

There are no affected markets at a horizontal and/or vertical level in the concentration considered, as the following statutory criteria are not cumulatively met in any relevant market: a) activity of at least two (2) of the parties to the concentration and a combined market share of at least 15% (regarding the horizontally affected markets) or b) activity of at least one of the parties to the concentration and a combined market share of at least 25% (regarding the vertically affected markets). In this respect, according to the evidence in the case file, the concentration is not expected to give rise to any conglomerate effects.

Judicial Means -
Μοιραστείτε το / Share it

Contact

Kotsika 1A & Patision
10434, Athens, Greece
210 8809100
contact(@)epant.gr

Social Media

Copyright

Copyright © 2024 Hellenic Competition Commission. All Rights Reserved.

ecn20

Θέλετε να ενημερώνεστε; Want to be updated?

Aκολουθήστε μας στα κοινωνικά δίκτυα!
Follow us on Social Media!